Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 05, 2024
Emmes has been selected by the National Institutes of Health's (NIH) NIDA [National Institute of Drug Abuse] to support their Clinical Trials Network (CTN) for a multi-task, IDIQ contract.
read more
Thursday, September 05, 2024
Vetter has successfully completed the first 100 clinical batches of liquid and lyophilized vials at its dedicated site in Rankweil, Austria. Vetter Development Services Austria supports the manufacturing and quality control of medicinal products for ...
read more
Thursday, September 05, 2024
Coronado Research is a consultancy-led, professional services organization operating in the clinical development arena.
read more
Monday, September 09, 2024
Invensify, Inc. and Senpex announced a partnership to enhance the delivery of temperature-sensitive pharmaceuticals. Through this collaboration, Senpex will incorporate Invensify's Insuridge™ shipping container into their logistics operations.
read more
Monday, September 09, 2024
Serán BioScience, LLC announced that it has completed an expansion to increase the number of process manufacturing suites at its facility in Bend, Oregon, from 6 to 14, adding approximately 130% more CGMP clinical manufacturing capacity.
read more
Monday, September 09, 2024
Symbiosis Pharmaceutical Services Ltd. announced the purchase of new premises in Stirling, Scotland, UK. The additional space will significantly increase manufacturing capacity, strengthen the current Symbiosis commercial manufacturing service ...
read more
Monday, September 09, 2024
Hongene Biotech Corporation, a nucleic acid manufacturing company, and ReciBioPharm, an advanced therapeutics CDMO services provider, have announced a strategic collaboration that will enhance gene editing drug manufacturing capabilities.
read more
Wednesday, September 11, 2024
Syntekabio an artificial intelligence (AI)-driven drug development company, announced the appointment of Joonhyuk Choi, former CEO of Target Health, as Head of US Operations.
Joonhyuk brings over 25 years of extensive experience in the ...
read more
Wednesday, September 11, 2024
Battelle and subcontractor CMC Pharmaceuticals announced their selection by the U.S. Department of Defense (DOD) to develop an improved nerve agent countermeasure to enhance the current standard of care for the warfighter and increase survivability.
read more
Wednesday, September 11, 2024
Novotech announced the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific (APAC) region, effective September 1, 2024.
read more
Wednesday, September 11, 2024
VS-041, a novel and potentially life-saving treatment for heart failure, developed by Vasa Therapeutics, a San Diego-based biotechnology company, has reached a major clinical milestone with the first human subjects dosed at Quotient Sciences’ ...
read more
Wednesday, September 11, 2024
UPS has agreed to acquire Frigo-Trans, and its sister company BPL, (together “Frigo-Trans”) industry-leading, complex healthcare logistics providers based in Germany. Once completed, the acquisition will enhance UPS’s end-to-end capabilities ...
read more
Wednesday, September 11, 2024
Pillar Biosciences, Inc. has entered into a strategic partnership with AstraZeneca to expand laboratory access to molecular testing, using rapid, Next Generation Sequencing (NGS)-based liquid biopsy tumor profiling panels for detection of genetic ...
read more
Thursday, September 12, 2024
PharmaForceIQ (PFIQ), the leading end to end Omnichannel Solution for Pharmaceutical Marketing, Medical and Clinical teams today announced a significant investment by Eir Partners (Eir) to accelerate adoption of the company’s unique technology ...
read more
Thursday, September 12, 2024
Temperature-controlled container specialists Tower Cold Chain and CRYOPDP have partnered to enhance their product offerings to the pharmaceutical supply chain. The collaboration aims to provide an expanded range of solutions, specifically for ...
read more